Article Text
Commentary
CDK20 inhibition and immune checkpoint blockade: bringing cancer biology and tumour immunology together to develop novel treatment options for HCC
Statistics from Altmetric.com
Footnotes
Contributors TFG and FK wrote the commentary.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.